Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

More rare birds, and the occasional swan.

Edlin BR, Shu MA, Winkelstein E, Des Jarlais DC, Busch MP, Rehermann B, O'Brien TR, Talal AH, Tobler LH, Zeremski M, Beeder AB.

Gastroenterology. 2009 Jun;136(7):2412-4. doi: 10.1053/j.gastro.2009.04.040. Epub 2009 May 3. No abstract available.

2.

HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA.

Garfein RS, Rondinelli A, Barnes RF, Cuevas J, Metzner M, Velasquez M, Rodriguez D, Reilly M, Xing J, Teshale EH.

J Urban Health. 2013 Jun;90(3):516-28. doi: 10.1007/s11524-012-9728-0.

3.
4.

Acute hepatitis C virus infection in an HIV clinic and in community settings.

Taylor LE, Mayer KH.

Gastroenterology. 2009 Jun;136(7):2411-2. doi: 10.1053/j.gastro.2009.04.043. Epub 2009 May 3. No abstract available.

PMID:
19409986
5.

Does hepatitis C virus really have no effect on survival in cases of infection with human immunodeficiency virus?

Jenny-Avital ER.

Clin Infect Dis. 2000 Feb;30(2):409-10. No abstract available.

PMID:
10671362
6.

Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City.

Des Jarlais DC, Diaz T, Perlis T, Vlahov D, Maslow C, Latka M, Rockwell R, Edwards V, Friedman SR, Monterroso E, Williams I, Garfein RS.

Am J Epidemiol. 2003 Mar 1;157(5):467-71.

PMID:
12615611
7.

Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001.

Des Jarlais DC, Perlis T, Arasteh K, Torian LV, Hagan H, Beatrice S, Smith L, Wethers J, Milliken J, Mildvan D, Yancovitz S, Friedman SR.

AIDS. 2005 Oct;19 Suppl 3:S20-5.

PMID:
16251819
8.

HCV rates outpacing HIV in NYC, study finds. New IDUs had greatest HCV burden.

[No authors listed]

AIDS Alert. 2004 Nov;19(11):128-9.

PMID:
15562535
9.

Hepatitis C virus and HIV infections among people who inject drugs in the Middle East and North Africa: a neglected public health burden?

Mumtaz GR, Weiss HA, Abu-Raddad LJ.

J Int AIDS Soc. 2015 Jul 28;18:20582. doi: 10.7448/IAS.18.1.20582. eCollection 2015. No abstract available.

10.

Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco.

Kral AH, Malekinejad M, Vaudrey J, Martinez AN, Lorvick J, McFarland W, Raymond HF.

J Urban Health. 2010 Sep;87(5):839-50. doi: 10.1007/s11524-010-9486-9.

11.

HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic.

Des Jarlais DC, Marmor M, Friedmann P, Titus S, Aviles E, Deren S, Torian L, Glebatis D, Murrill C, Monterroso E, Friedman SR.

Am J Public Health. 2000 Mar;90(3):352-9.

12.

A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.

Removille N, Origer A, Couffignal S, Vaillant M, Schmit JC, Lair ML.

BMC Public Health. 2011 May 19;11:351. doi: 10.1186/1471-2458-11-351.

13.

Risk behaviours for infection with HIV and hepatitis C virus among people who inject drugs in Regina, Saskatchewan.

Hennink M, Abbas Z, Choudhri Y, Diener T, Lloyd K, Archibald CP, Cule S.

Can Commun Dis Rep. 2007 Mar 1;33(5):53-9. English, French. No abstract available.

14.

Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.

Kim NJ, Jin H, McFarland W, Raymond HF.

Int J Drug Policy. 2015 Dec;26(12):1238-43. doi: 10.1016/j.drugpo.2015.08.013. Epub 2015 Aug 22.

PMID:
26365768
15.

Hepatitis C infection among men who have sex with men, San Francisco, 2011.

Raymond HF, Chu P, Nieves-Rivera I, Louie B, McFarland W, Pandori M.

Sex Transm Dis. 2012 Dec;39(12):985-6. doi: 10.1097/OLQ.0b013e3182716e59.

PMID:
23191955
16.

Epidemiology of human immunodeficiency virus type 1 infection among homosexual men participating in hepatitis B vaccine trials in Amsterdam, New York City, and San Francisco, 1978-1990.

van Griensven GJ, Hessol NA, Koblin BA, Byers RH, O'Malley PM, Albercht-van Lent N, Buchbinder SP, Taylor PE, Stevens CE, Coutinho RA.

Am J Epidemiol. 1993 Apr 15;137(8):909-15.

PMID:
8484382
17.

Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons.

Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, Rich JD.

Am J Public Health. 2004 Jul;94(7):1218-23. Erratum in: Am J Public Health. 2004 Nov;94(11):1847.

18.

Retrospective cohort study examining incidence of HIV and hepatitis C infection among injecting drug users in Dublin.

Smyth BP, O'Connor JJ, Barry J, Keenan E.

J Epidemiol Community Health. 2003 Apr;57(4):310-1. No abstract available.

19.

Introduction: The New York HIV-drug use epidemic: lessons learned and unresolved issues.

Deren S, Hagan H.

Subst Use Misuse. 2011;46(2-3):129-30. doi: 10.3109/10826084.2011.521455. No abstract available.

PMID:
21303232
20.

Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City.

Des Jarlais DC, Arasteh K, McKnight C, Hagan H, Perlman D, Friedman SR.

Drug Alcohol Depend. 2009 Apr 1;101(1-2):88-91. doi: 10.1016/j.drugalcdep.2008.11.007. Epub 2008 Dec 23.

PMID:
19108958

Supplemental Content

Support Center